Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


In Brief: CompuMed

This article was originally published in The Gray Sheet

Executive Summary

CompuMed: Plans to commence clinical trials in the fourth quarter for its OsteoView 2000 digital system for osteoporosis and arthritis detection. The system incorporates "image processing and segmentation tools," as well as a "high resolution direct digital x-ray capture technology," CompuMed explains. The device, for which Manhattan Beach, California-based CompuMed will seek 510(k) market clearance, "is expected to be the first machine in the world to enable diagnosis of both osteoporosis and arthritis," the firm maintains...



Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts